Ethical, translational, and legal issues surrounding the novel adoption of ectogestative technologies

S Segers, EC Romanis - Risk management and healthcare policy, 2022 - Taylor & Francis
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …
被引用次数：11 相关文章

Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk Management and …, 2022 - cris.maastrichtuniversity.nl
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as" artificial womb …

Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, E Romanis - Risk Management and Healthcare Policy, 2022 - europepmc.org
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …

Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk …, 2022 - durham-repository.worktribe.com
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …

Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk Management and Healthcare …, 2022 - search.proquest.com
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …

Ethical, translational, and legal issues surrounding the novel adoption of ectogestative technologies

S Segers, EC Romanis - RISK MANAGEMENT AND HEALTHCARE …, 2022 - biblio.ugent.be
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as" artificial womb …
[HTML] nih.gov

[HTML][HTML] Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk Management and Healthcare Policy, 2022 - ncbi.nlm.nih.gov
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …

Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk management and …, 2022 - pubmed.ncbi.nlm.nih.gov
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as" artificial womb …
[PDF] semanticscholar.org

[PDF][PDF] Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk Management and …, 2022 - pdfs.semanticscholar.org
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …

Ethical, Translational, and Legal Issues Surrounding the Novel Adoption of Ectogestative Technologies

S Segers, EC Romanis - Risk Management and Healthcare Policy, 2022 - dovepress.com
Increasing numbers of research teams are investigating the feasibility of developing artificial
amnion and placenta technology (AAPT), commonly referred to as “artificial womb …